The global T-cell therapy market size is expected to reach USD 21 Billion in 2028 and register a CAGR of 20.4% over the forecast period, according to the latest report by Reports and Data. Key factors such as increasing geriatric population globally, rising awareness about advanced cancer treatments, and major prevalence of cancers are driving market revenue growth. T-cell therapy is a type of immunotherapy that involves genetic modification of T-cells. This process is used to treat different types of cancers.
There are mainly three main types of T-cell therapies; CAR T-cell therapy, T-cell receptor (TCR)-based, and tumor infiltrating lymphocytes (TIL)-based. CAR T-cell therapy or Chimeric Antigen Receptor T-cell therapy is one of the most effective methods of cancer treatment. CAR T-cell therapy segment accounted for majority revenue share in the global market in 2020. This can be attributed to increasing number of clinical trials for CAR T-cell therapy and increasing investment in research related to CAR T-cell therapy.
North America accounted for second-largest revenue share in the global market in 2020. Major revenue contributors to revenue of the North America market are the United States and Canada, respectively. Factors such as growing number of clinical trials of T-cell therapies being conducted are driving revenue growth of the market in this region.
Asia Pacific market accounted for a 23.2% revenue share in the global market in 2020 and is expected to register fastest CAGR than other regional markets over the forecast period. This can be attributed to growing focus on cancer research, and ongoing development of healthcare sector.
Europe accounted for a significant revenue share in 2020 and the trend is expected to continue over the forecast period. Increasing application of T-cell therapy in different cancer treatments is one of the key factors driving revenue growth of the market in this region.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2508
Some Key Highlights from the Report:
- In January 2021, OrganaBio launched a new cell product, ImmunoPAC-T-CB T cells. These cells are obtained from full-term umbilical cord blood taken from donors that supports allogeneic immune cell-based therapy development.
- Research segment accounted for largest revenue share in the global market in 2020. This can be attributed to rising focus on research of T-cell therapy, and increasing investment in cell therapy-based clinical research and development activities.
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The T-Cell Therapy market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
- Novartis AG
- Merck KGaA
- Gilead Sciences Inc.
- TCR2 Therapeutics Inc.
- Bluebird Bio Inc.
- Sorrento Therapeutics
- Fate Therapeutics
- Pfizer Inc.
- Amgen
- Celgene Corporation
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2508
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
T-Cell Therapy Market Segmentation:
Modality Outlook:
- Research
- Commercialized
Therapy Outlook:
- CAR T-cell therapy
- T-cell receptor (TCR)-based
- Tumor infiltrating lymphocytes (TIL)-based.
Indication Outlook:
- Hematologic Malignancies
- Lymphoma
- Myeloma
- Leukemia
- Solid Tumors
- Brain & Central Nervous System
- Liver Cancer
- Melanoma
- Others
Geographic Segment Covered in the Report:
The T-Cell Therapy report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)
Browse Full Report Description with Research Methodology, Table of Content, and Infographics @ https://www.reportsanddata.com/report-detail/t-cell-therapy-market
Key market aspects are illuminated in the report:
- Executive Summary: It covers a summary of the most vital studies, the Global T-Cell Therapy market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
- Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global T-Cell Therapy market, the years measured, and the study points.
- Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.
- Manufacture by Region: This Global T-Cell Therapy report offers data on imports and exports, sales, production and key companies in all studied regional markets.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2508
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Plethysmograph Market @ https://www.biospace.com/article/plethysmograph-market-is-expected-to-register-a-revenue-cagr-of-5-3-percent-between-2022-and-2030/
Panic Disorder Market @ https://www.biospace.com/article/panic-disorder-market-growth-analysis-by-2030-increase-in-the-number-of-people-being-diagnosed-with-panic-disorder-particularly-as-a-result-of-increasing-mental-issues/
Onychomycosis Disease Market @ https://www.biospace.com/article/onychomycosis-disease-market-growth-analysis-by-2030-rising-prevalence-of-dermatophyte-caused-nail-fungal-infection-is-drive-revenue-growth-in-the-industry/
Myelodysplastic Syndrome Disease Market @ https://www.biospace.com/article/asia-pacific-market-is-predicted-to-increase-significantly-in-terms-of-cagr-in-the-global-myelodysplastic-syndrome-disease-market/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs